Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-FR Version v2-FR
Language French French
Date Updated 2017-06-08 2017-03-10
Drug Identification Number 00487872 00487872
Brand name APO CIMETIDINE TAB 300MG APO CIMETIDINE TAB 300MG
Common or Proper name CIMETIDINE CIMETIDINE
Company Name AA PHARMA INC AA PHARMA INC
Ingredients CIMETIDINE CIMETIDINE
Strength(s) 300MG 300MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1000 BTL 1000 BTL
ATC code A02BA A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-01 2017-03-10
Estimated end date 2017-06-09 2017-04-30
Actual end date 2017-06-07
Shortage status Resolved Anticipated shortage
Company comments APO-CIMETIDINE 300 MG FCT 100 BTL is available APO-CIMETIDINE 300 MG FCT 100 BTL is available
Health Canada comments